BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

548 related articles for article (PubMed ID: 29229189)

  • 1. Immunoproteasome inhibition prevents chronic antibody-mediated allograft rejection in renal transplantation.
    Li J; Basler M; Alvarez G; Brunner T; Kirk CJ; Groettrup M
    Kidney Int; 2018 Mar; 93(3):670-680. PubMed ID: 29229189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoproteasome inhibition induces plasma cell apoptosis and preserves kidney allografts by activating the unfolded protein response and suppressing plasma cell survival factors.
    Li J; Koerner J; Basler M; Brunner T; Kirk CJ; Groettrup M
    Kidney Int; 2019 Mar; 95(3):611-623. PubMed ID: 30685098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcineurin Inhibitor Minimization With Ixazomib, an Investigational Proteasome Inhibitor, for the Prevention of Antibody Mediated Rejection in a Preclinical Model.
    Reese SR; Wilson NA; Huang G; Redfield RR; Zhong W; Djamali A
    Transplantation; 2015 Sep; 99(9):1785-95. PubMed ID: 25919767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No prolongation of skin allograft survival by immunoproteasome inhibition in mice.
    Mundt S; Basler M; Sawitzki B; Groettrup M
    Mol Immunol; 2017 Aug; 88():32-37. PubMed ID: 28582644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophages contribute to cellular but not humoral mechanisms of acute rejection in rat renal allografts.
    Ma FY; Woodman N; Mulley WR; Kanellis J; Nikolic-Paterson DJ
    Transplantation; 2013 Dec; 96(11):949-57. PubMed ID: 24056626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-inhibition of immunoproteasome subunits LMP2 and LMP7 enables prevention of transplant arteriosclerosis.
    Li J; Hu S; Johnson HWB; Kirk CJ; Xian P; Song Y; Li Y; Liu N; Groettrup M; Basler M
    Cardiovasc Res; 2023 May; 119(4):1030-1045. PubMed ID: 36464772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Sirtuin-1 prolongs murine renal allograft survival and function.
    Levine MH; Wang Z; Xiao H; Jiao J; Wang L; Bhatti TR; Hancock WW; Beier UH
    Kidney Int; 2016 May; 89(5):1016-1026. PubMed ID: 27083279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Model of Acute Antibody-Mediated Renal Allograft Rejection in the Sensitized Rata.
    Chandran SR; Mulley WR; Kanellis J; Nikolic-Paterson DJ; Ma FY
    Exp Clin Transplant; 2018 Jun; 16(3):294-300. PubMed ID: 28760115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FK778, a powerful new immunosuppressant, effectively reduces functional and histologic changes of chronic rejection in rat renal allografts.
    Pan F; Ebbs A; Wynn C; Erickson L; Jang MS; Crews G; Fisniku O; Kobayashi M; Paul LC; Benediktsson H; Jiang AH
    Transplantation; 2003 Apr; 75(8):1110-4. PubMed ID: 12717186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In the absence of natural killer cell activation donor-specific antibody mediates chronic, but not acute, kidney allograft rejection.
    Yagisawa T; Tanaka T; Miyairi S; Tanabe K; Dvorina N; Yokoyama WM; Valujskikh A; Baldwin WM; Fairchild RL
    Kidney Int; 2019 Feb; 95(2):350-362. PubMed ID: 30503624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spleen tyrosine kinase contributes to acute renal allograft rejection in the rat.
    Ramessur Chandran S; Tesch GH; Han Y; Woodman N; Mulley WR; Kanellis J; Blease K; Ma FY; Nikolic-Paterson DJ
    Int J Exp Pathol; 2015 Feb; 96(1):54-62. PubMed ID: 25529862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tofacitinib Halts Progression of Graft Dysfunction in a Rat Model of Mixed Cellular and Humoral Rejection.
    Rovira J; Ramírez-Bajo MJ; Banon-Maneus E; Lazo-Rodríguez M; Moya-Rull D; Hierro-Garcia N; Tubita V; Piñeiro GJ; Revuelta I; Ventura-Aguiar P; Cucchiari D; Oppenheimer F; Brunet M; Campistol JM; Diekmann F
    Transplantation; 2018 Jul; 102(7):1075-1084. PubMed ID: 29620612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretransplant Desensitization with Costimulation Blockade and Proteasome Inhibitor Reduces DSA and Delays Antibody-Mediated Rejection in Highly Sensitized Nonhuman Primate Kidney Transplant Recipients.
    Ezekian B; Schroder PM; Mulvihill MS; Barbas A; Collins B; Freischlag K; Yoon J; Yi JS; Smith F; Olaso D; Saccoccio FM; Permar S; Farris AB; Kwun J; Knechtle SJ
    J Am Soc Nephrol; 2019 Dec; 30(12):2399-2411. PubMed ID: 31658991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PG490-88, a new immunosuppressant, effectively prevents acute and chronic rejection in rat renal allografts.
    Pan F; Fisniku O; Wynn C; Erickson LM; Crews G; Jang MS; Sudo Y; Tamura K; Kobayashi M; Benediktsson H; Jiang H
    Transplant Proc; 2005; 37(1):134-6. PubMed ID: 15808572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triptolide inhibits donor-specific antibody production and attenuates mixed antibody-mediated renal allograft injury.
    Zhao D; Li S; Liao T; Wei Y; Liu M; Han F; Luo Z; Liu X; Sun Q
    Am J Transplant; 2018 May; 18(5):1083-1095. PubMed ID: 29178433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative analysis between proteasome and immunoproteasome inhibition in cellular and humoral alloimmunity.
    Eleftheriadis T; Pissas G; Antoniadi G; Liakopoulos V; Stefanidis I
    Int Immunopharmacol; 2017 Sep; 50():48-54. PubMed ID: 28628770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteasome inhibitor-based therapy for antibody-mediated rejection.
    Walsh RC; Alloway RR; Girnita AL; Woodle ES
    Kidney Int; 2012 Jun; 81(11):1067-74. PubMed ID: 22336990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mTOR Inhibition Suppresses Posttransplant Alloantibody Production Through Direct Inhibition of Alloprimed B Cells and Sparing of CD8+ Antibody-Suppressing T cells.
    Avila CL; Zimmerer JM; Elzein SM; Pham TA; Abdel-Rasoul M; Bumgardner GL
    Transplantation; 2016 Sep; 100(9):1898-906. PubMed ID: 27362313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral Platelet-Derived Growth Factor and Vascular Endothelial Growth Factor Inhibitor Sunitinib Prevents Chronic Allograft Injury in Experimental Kidney Transplantation Model.
    Rintala JM; Savikko J; Palin N; Rintala SE; Koskinen PK; von Willebrand E
    Transplantation; 2016 Jan; 100(1):103-10. PubMed ID: 26262503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Memory CD4 T Cells Induce Antibody-Mediated Rejection of Renal Allografts.
    Gorbacheva V; Fan R; Fairchild RL; Baldwin WM; Valujskikh A
    J Am Soc Nephrol; 2016 Nov; 27(11):3299-3307. PubMed ID: 27020853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.